Clinical Trials

  • Weight Loss Study: Genetic Variations and Response to Naltrexone/Bupropion

    Principal Investigator:

    Judy Korner, MD
    The purpose of this study is to evaluate if genetic variations are associated with the amount of weight loss with diet and while taking an FDA-approved medication for weight loss. The participation lasts ten months and includes six in-person visits at CUIMC with blood sampling and questionnaires, virtual nutritional counseling, and taking an oral weight loss medication for 28 weeks.

Pages